ReviewTransplantation2026
Patient-reported Outcome Measures in Solid Organ Transplant Recipients: Current use, Challenges, and Recommendations for Future use.
Review in Transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Worldwide, the number of patients receiving solid organ transplantation each year is increasing. In recent years, there has been growing recognition of the need to understand how these additional life years are experienced and valued by recipients. Patient-reported outcomes (PROs)-such as symptoms, functioning, and health-related quality of life-provide direct insight into health from the patient's perspective and are increasingly acknowledged as key outcomes in both research and clinical care. Different patient-reported outcome measures (PROMs) have been developed in the field of transplantation. However, their current use in both clinical care and research in solid organ transplant recipients remains inconsistent and limited. This narrative review summarizes the current state of PRO and PROM use in solid organ transplantation across different organs and settings, highlights recent initiatives and ongoing implementation efforts, and outlines challenges in PROM selection, application and interpretation. Although the field of kidney transplantation is currently leading in the development and implementation of PROM initiatives, comparable efforts in liver, lung, and heart transplantation remain limited, resulting in slow and heterogeneous progress across organ domains. To support broader adoption, we propose a stepwise roadmap for PROM implementation in transplantation. A more systematic and thoughtful integration of PROs and PROMs holds potential to improve shared decision-making, generate evidence that aligns more closely with the priorities of transplant recipients, and ultimately support more meaningful clinical decisions and improved outcomes for transplant recipients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.